Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

8.81
BATS BZX Real-Time Price
As of 2:39pm ET
 +0.49 / +5.89%
Today’s Change
6.91
Today|||52-Week Range
14.50
-5.37%
Year-to-Date
No recent news for Vanda Pharmaceuticals Inc.

Today’s Trading

Previous close8.32
Today’s open8.52
Day’s range8.18 - 8.91
Volume31,346
Average volume (3 months)554,354
Market cap$359.0M
Dividend yield--
Data as of 2:39pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)-45.56%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.03-0.47%
PGNXProgenics Pharmaceut...-0.24-4.62%
MRTXMirati Therapeutics ...-0.25-1.33%
AKBAAkebia Therapeutics ...-0.11-1.20%
Data as of 2:40pm ET, 05/05/2016

Financials

Last reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

Partner Offers

Search for Jobs